Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Non-cash Items: 2012-2016

Historic Non-cash Items for Agios Pharmaceuticals (AGIO) over the last 5 years, with Dec 2016 value amounting to $63.6 million.

  • Agios Pharmaceuticals' Non-cash Items rose 27.27% to $2.9 million in Q1 2017 from the same period last year, while for Mar 2017 it was $2.9 million, marking a year-over-year increase of 27.27%. This contributed to the annual value of $63.6 million for FY2016, which is 58.61% down from last year.
  • As of FY2016, Agios Pharmaceuticals' Non-cash Items stood at $63.6 million, which was down 58.61% from $153.6 million recorded in FY2015.
  • In the past 5 years, Agios Pharmaceuticals' Non-cash Items ranged from a high of $360.9 million in FY2014 and a low of $2.2 million during FY2013.
  • For the 3-year period, Agios Pharmaceuticals' Non-cash Items averaged around $192.7 million, with its median value being $153.6 million (2015).
  • In the last 5 years, Agios Pharmaceuticals' Non-cash Items plummeted by 85.97% in 2013 and then spiked by 16,599.65% in 2014.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Non-cash Items stood at $15.4 million in 2012, then slumped by 85.97% to $2.2 million in 2013, then surged by 16,599.65% to $360.9 million in 2014, then crashed by 57.45% to $153.6 million in 2015, then plummeted by 58.61% to $63.6 million in 2016.